Herborium Group, Inc. (HBRM)

Dr. Agnes Olszewski, CEO of Herborium Group, Speaks About Growth and Opportunities for Their Signature Botanical Treatment for Acne in Uptick Newswire Radio Interview


Fort Lee, NJ -- (ReleaseWire) -- 12/13/2016 --Herborium® Group, Inc. (OTCPink:HBRM), a Botanical Therapeutics® Company providing unique, all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne as well as other health and wellness concerns, announced today that a radio interview with its CEO, Dr. Agnes P. Olszewski, is available on a number of public venues including:

UPTICK Newswire Radio - https://upticknewswire.com/dr-agnes-olszewski-ceo-of-herborium-group-talks-about-their-signature-botanical-treatment-for-acne/

Investors Hangout: https://investorshangout.com

Google Play: https://play.google.com/music/m/Dtpzvif6zs2t4fdsuat2odamiiu?t=Dr_Agnes_Olszewski_CEO_of_Herborium_Group_talks_About_their_Signature_Botanical_Treatment_for_Acne-U

iTunes - https://itunes.apple.com/us/podcast/uptick-network/id1076183234?mt=2&ign-mpt=uo%3D4#

iHeartRADIO: http://www.iheart.com/show/53-Uptick-Network/

Audio Boom!: https://audioboom.com/posts/5374060-dr-agnes-olszewski-ceo-of-herborium-group-talks-about-their-signature-botanical-treatment-for-acne

Dr. Agnes talks about the Company's two-digit growth over the last eight quarters, the unprecedented 105% increase in sales for 2016 Cyber Monday and Black Friday, and the global opportunities for Herborium's unique Botanical Therapeutics®.

The global nutraceutical market is valued at about USD $250 billion in 2016 and is expected to reach around USD $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth.

Dr Agnes also discusses a differential advantage of Herborium's signature product for acne, AcnEase®, and the Company's other Botanical Therapeutics® offering insight to the Company's strategy for continuous growth in 2017.

Recent sales results continue to surpass Herborium's 2015 performance and the Company expects record results in 2016. (The combined sales for the first three quarters of 2016 grew by 14% in comparison to the same period of 2015).

Over 75 million people suffer from acne in the USA alone, with an additional120 million sufferers, from this reoccurring problem, in Europe. Seventy five percent of all individuals will suffer from acne at some point in their lives. The average age of the acne sufferer has increased during the past decade from 21 years old to 26 years old, making adult acne an epidemic.

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects.

The acne treatment and prevention market is growing while at the same time no new medical products are emerging and the number of previously used treatment options is decreasing or are restricted due to recognized health concerns. (i.e. Accutane, antibiotics, oral contraceptives)

With the growing need for its signature product, new products in the pipeline and its unique expertise, Herborium Group is in an ideal position to take advantage of emerging nutraceutical market trends and to meet more demanding manufacturing and regulatory standards for the industry.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's sexual health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com
Website: http://www.herborium.com
Phone: 201-849-4431

Source: Uptick Newswire